Intellicentic has developed deterministic models that are currently optimizing the enzymatic reactions used in pharmaceutical production. Steady state optimization is maximizing throughput and yield at a production neutral cost, while cycle time is being reduced to improve productivity.
We are now addressing the need to move from pulse purging (a strategy that tries to cope with impurity buildup in reactors) to continuous purging strategies. Please see our What is Intellicentic? page to read about how we can help move your company away from coping strategies to proactive strategies.